Jarislowsky, Fraser LTD Eli Lilly & CO Transaction History

Jarislowsky, Fraser LTD

$16.1 Billion
Q3 2024

A detailed history of Jarislowsky, Fraser LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Jarislowsky, Fraser LTD holds 23,749 shares of LLY stock, worth $18.9 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

23,749

Previous 25,772 7.85%

Holding current value

$18.9 Million

Previous $23.3 Million 9.83%

% of portfolio

0.13%

Previous 0.16%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $1.56 Million - $1.94 Million	-2,023 Reduced 7.85%	23,749 $21 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $4.27 Million - $5.36 Million	-5,895 Reduced 18.62%	25,772 $23.3 Million
Q1 2024 Sep 30, 2024	SELL	$592.2 - $792.28 $4.15 Million - $5.55 Million	-7,003 Reduced 18.11%	31,667 $24.6 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $4.15 Million - $5.55 Million	-7,003 Reduced 18.11%	31,667 $24.6 Million
Q4 2023 Sep 30, 2024	BUY	$525.19 - $619.13 $6.77 Million - $7.99 Million	12,898 Added 50.05%	38,670 $22.5 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $382,338 - $450,726	-728 Reduced 1.85%	38,670 $22.5 Million
Q3 2023 Sep 30, 2024	BUY	$434.7 - $599.3 $5.92 Million - $8.17 Million	13,626 Added 52.87%	39,398 $21.2 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $998,940 - $1.38 Million	-2,298 Reduced 5.51%	39,398 $21.2 Million
Q2 2023 Sep 27, 2024	SELL	$350.74 - $468.98 $6.23 Million - $8.33 Million	-17,767 Reduced 29.88%	41,696 $19.6 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $6.23 Million - $8.33 Million	-17,767 Reduced 29.88%	41,696 $19.6 Million
Q1 2023 Sep 27, 2024	BUY	$310.63 - $364.82 $10.5 Million - $12.3 Million	33,691 Added 130.73%	59,463 $20.4 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $464,081 - $545,041	-1,494 Reduced 2.45%	59,463 $20.4 Million
Q4 2022 Sep 27, 2024	BUY	$321.55 - $374.67 $11.3 Million - $13.2 Million	35,185 Added 136.52%	60,957 $22.3 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $76,788 - $87,508	-259 Reduced 0.42%	60,957 $19.7 Million
Q2 2022 Jul 27, 2022	SELL	$278.73 - $327.27 $208,211 - $244,470	-747 Reduced 1.21%	61,216 $19.8 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $234,690 - $291,660	-1,000 Reduced 1.59%	61,963 $17.7 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $2.11 Million - $2.62 Million	-9,403 Reduced 12.99%	62,963 $17.4 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $337,940 - $415,882	-1,525 Reduced 2.06%	72,366 $16.7 Million
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $2.91 Million - $3.77 Million	-16,130 Reduced 17.92%	73,891 $17 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $809,276 - $1.05 Million	-4,925 Reduced 5.19%	90,021 $16.8 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $104,368 - $138,104	-800 Reduced 0.84%	94,946 $16 Million
Q3 2020 Nov 03, 2020	SELL	$146.22 - $169.13 $10,966 - $12,684	-75 Reduced 0.08%	95,746 $14.2 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $144,605 - $174,030	-1,060 Reduced 1.09%	95,821 $15.7 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $318,458 - $394,161	-2,675 Reduced 2.69%	96,881 $13.4 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $10,679 - $11,616	-100 Reduced 0.1%	99,556 $11.1 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $337,909 - $394,426	-3,050 Reduced 2.97%	99,656 $11 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $95,726 - $112,677	860 Added 0.84%	102,706 $13.3 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $12,879 - $16,096	-150 Reduced 0.15%	101,846 $11 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $78,349 - $89,920	-1,035 Reduced 1.0%	101,996 $8.7 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $2,300 - $2,715	-31 Reduced 0.03%	103,031 $0
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $21,714 - $23,290	-265 Reduced 0.26%	103,062 $0
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $7.96 Million - $8.84 Million	103,327	103,327 $8.84 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jarislowsky, Fraser LTD with notifications on news.

Account

Jarislowsky, Fraser LTD Eli Lilly & CO Transaction History